260 related articles for article (PubMed ID: 30706395)
1. Current Use of Adenovirus Vectors and Their Production Methods.
Sayedahmed EE; Kumari R; Mittal SK
Methods Mol Biol; 2019; 1937():155-175. PubMed ID: 30706395
[TBL] [Abstract][Full Text] [Related]
2. Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials.
Kallel H; Kamen AA
Biotechnol J; 2015 May; 10(5):741-7. PubMed ID: 25914340
[TBL] [Abstract][Full Text] [Related]
3. Good manufacturing practice production of adenoviral vectors for clinical trials.
Lusky M
Hum Gene Ther; 2005 Mar; 16(3):281-91. PubMed ID: 15812223
[TBL] [Abstract][Full Text] [Related]
4. From the first to the third generation adenoviral vector: what parameters are governing the production yield?
Dormond E; Perrier M; Kamen A
Biotechnol Adv; 2009; 27(2):133-44. PubMed ID: 19013226
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus vector system: construction, history and therapeutic applications.
Syyam A; Nawaz A; Ijaz A; Sajjad U; Fazil A; Irfan S; Muzaffar A; Shahid M; Idrees M; Malik K; Afzal S
Biotechniques; 2022 Dec; 73(6):297-305. PubMed ID: 36475496
[TBL] [Abstract][Full Text] [Related]
6. Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls.
Appaiahgari MB; Vrati S
Expert Opin Biol Ther; 2015 Mar; 15(3):337-51. PubMed ID: 25529044
[TBL] [Abstract][Full Text] [Related]
7. Use of recombinant adenovirus for metabolic engineering of mammalian cells.
Becker TC; Noel RJ; Coats WS; Gómez-Foix AM; Alam T; Gerard RD; Newgard CB
Methods Cell Biol; 1994; 43 Pt A():161-89. PubMed ID: 7823861
[No Abstract] [Full Text] [Related]
8. [Producing recombinant adenovirus encoding green fluorescent protein (Ad-GFP) by suspension cultured HEK-293 N3S cells].
Tian B; Wu B; Zhang QW; Bi JJ; Wang L; Zhu BZ; Geng Y; Wu ZZ
Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):915-8. PubMed ID: 18051875
[TBL] [Abstract][Full Text] [Related]
9. Physical and infectious titers of helper-dependent adenoviral vectors: a method of direct comparison to the adenovirus reference material.
Palmer DJ; Ng P
Mol Ther; 2004 Oct; 10(4):792-8. PubMed ID: 15451463
[TBL] [Abstract][Full Text] [Related]
10. A rapid protocol for construction and production of high-capacity adenoviral vectors.
Jager L; Hausl MA; Rauschhuber C; Wolf NM; Kay MA; Ehrhardt A
Nat Protoc; 2009; 4(4):547-64. PubMed ID: 19373227
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus vectors: biology, design, and production.
Imperiale MJ; Kochanek S
Curr Top Microbiol Immunol; 2004; 273():335-57. PubMed ID: 14674606
[TBL] [Abstract][Full Text] [Related]
12. Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting.
Jönsson F; Hagedorn C; Kreppel F
J Vis Exp; 2018 Oct; (140):. PubMed ID: 30417881
[TBL] [Abstract][Full Text] [Related]
13. Viral Vector Production: Adenovirus.
Kim JW; Morshed RA; Kane JR; Auffinger B; Qiao J; Lesniak MS
Methods Mol Biol; 2016; 1382():115-30. PubMed ID: 26611583
[TBL] [Abstract][Full Text] [Related]
14. Respiratory muscles as a target for adenovirus-mediated gene therapy.
Petrof BJ
Eur Respir J; 1998 Feb; 11(2):492-7. PubMed ID: 9551759
[TBL] [Abstract][Full Text] [Related]
15. Viral vectors for gene transfer: a review of their use in the treatment of human diseases.
Walther W; Stein U
Drugs; 2000 Aug; 60(2):249-71. PubMed ID: 10983732
[TBL] [Abstract][Full Text] [Related]
16. Enhanced preparation of adeno-associated viral vectors by using high hydrostatic pressure to selectively inactivate helper adenovirus.
Leonard JN; Ferstl P; Delgado A; Schaffer DV
Biotechnol Bioeng; 2007 Aug; 97(5):1170-9. PubMed ID: 17252611
[TBL] [Abstract][Full Text] [Related]
17. Manufacturing of adenovirus vectors: production and purification of helper dependent adenovirus.
Dormond E; Kamen AA
Methods Mol Biol; 2011; 737():139-56. PubMed ID: 21590396
[TBL] [Abstract][Full Text] [Related]
18. Effect of ammonia production on intracellular pH: Consequent effect on adenovirus vector production.
Ferreira TB; Carrondo MJ; Alves PM
J Biotechnol; 2007 May; 129(3):433-8. PubMed ID: 17313985
[TBL] [Abstract][Full Text] [Related]
19. Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model.
Hrycak CP; Windmann S; Bayer W
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375593
[TBL] [Abstract][Full Text] [Related]
20. High-titer adenovirus vector production in 293S cell perfusion culture.
Cortin V; Thibault J; Jacob D; Garnier A
Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
